Berberine Impairs the Survival of Triple Negative Breast Cancer Cells: Cellular and Molecular Analyses
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Berberine Impairs the Survival of Triple Negative Breast Cancer Cells: Cellular and Molecular Analyses
Authors
Keywords
-
Journal
MOLECULES
Volume 25, Issue 3, Pages 506
Publisher
MDPI AG
Online
2020-01-28
DOI
10.3390/molecules25030506
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Natural Isoquinoline Alkaloid With Antitumor Activity: Studies of the Biological Activities of Berberine
- (2019) Da Liu et al. Frontiers in Pharmacology
- Different mechanisms involved in the berberine‐induced antiproliferation effects in triple‐negative breast cancer cell lines
- (2019) Yen‐Shu Lin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell
- (2019) Mingjiang Yao et al. BMC Complementary and Alternative Medicine
- Berberine Suppresses Cell Motility Through Downregulation of TGF-β1 in Triple Negative Breast Cancer Cells
- (2018) Sangmin Kim et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Cyclizing-berberine A35 induces G2/M arrest and apoptosis by activating YAP phosphorylation (Ser127)
- (2018) Wuli Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Berberine down-regulates IL-8 expression through inhibition of the EGFR/MEK/ERK pathway in triple-negative breast cancer cells
- (2018) Sangmin Kim et al. PHYTOMEDICINE
- Potential role of targeted therapies in the treatment of triple-negative breast cancer
- (2016) Lee Yueh Jia et al. ANTI-CANCER DRUGS
- Current knowledge and pharmacological profile of berberine: An update
- (2015) Anil Kumar et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Induction of G2/M Arrest by Berberine via Activation of PI3K/Akt and p38 in Human Chondrosarcoma Cell Line
- (2015) Seong-Hui Eo et al. ONCOLOGY RESEARCH
- Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
- (2015) Mark A. Feitelson et al. SEMINARS IN CANCER BIOLOGY
- Effect of berberine on cell cycle arrest and cell survival during cerebral ischemia and reperfusion and correlations with p53/cyclin D1 and PI3K/Akt
- (2013) Yu-Shuang Chai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Triple-negative breast cancer: epidemiological considerations and recommendations
- (2012) P. Boyle ANNALS OF ONCOLOGY
- Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer
- (2012) V. Maire et al. CANCER RESEARCH
- NPACT: Naturally Occurring Plant-based Anti-cancer Compound-Activity-Target database
- (2012) Manu Mangal et al. NUCLEIC ACIDS RESEARCH
- Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway
- (2010) Jeevitha B. Patil et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Berberine inhibits cyclin D1 expression via suppressed binding of AP-1 transcription factors to CCND1 AP-1 motif
- (2008) Ye LUO et al. ACTA PHARMACOLOGICA SINICA
- Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine
- (2008) Mohsen Imanshahidi et al. PHYTOTHERAPY RESEARCH
- Berberine Inhibits Growth of the Breast Cancer Cell Lines MCF-7 and MDA-MB-231
- (2008) Jong Kim et al. PLANTA MEDICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started